Press release
Pertussis Market Analysis 2032: Epidemiology, FDA Approvals, Clinical Trials, Therapies, Companies by DelveInsight | Sanofi Pasteur, Mitsubishi Tanabe Pharma, GlaxoSmithKline, ILiAD Biotechnologies
Pertussis Market
DelveInsight's "Pertussis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Pertussis, historical and forecasted epidemiology as well as the Pertussis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Pertussis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Pertussis market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Pertussis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Pertussis market.
Request for a Free Sample Report @ [https://www.delveinsight.com/report-store/pertussis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Some facts of Pertussis Market Report are:
* According to DelveInsight, Pertussis Market to Garner Considerable Growth at 1.4% CAGR by 2030.
* The current prophylatic Pertussis market is already quite strong with GSK and Sanofi leading the space. Pertussis market comprises of DTaP vaccines and Tdap vaccines mainly, which include approved vaccines such as Adacel, Boostrix, Pediarix, Pentacel, Vaxelis, Others [Daptacel, Infanrix, Tetraxim, Pentaxim in the US; Boostrix, Repevax/Adacel Hexaxim/Hexyon/Hexacima, Vaxelis, Infanrix Hexa, Others [Daptacel, Infanrix, Tetraxim, Pentaxim] in the EU-5 countries, and Tetrabik, Tribik/BK1301 and Quattrovac in Japan.
* Several key pharmaceutical Pertussis companies, including Sanofi Pasteur, Mitsubishi Tanabe Pharma, GlaxoSmithKline, ILiAD Biotechnologies, Serum Institute, Bilthoven, Vakzine Projekt Management GmbH (VPM), Cansino Bio, China National Biotec Group and Beijing Institute of Biological Products, and others, are developing novel products to improve the Pertussis treatment outlook.
* Daiichi Sankyo, Mitsubishi Tanabe Pharma Corporation, and KM Biologics supply pertussis vaccinations in Japan. Mitsubishi is now leading the Japanese vaccination market with Tetrabik.
* Countries like France and Italy have made pertussis vaccinations mandatory, while it is recommended in the vaccination schedules of the US, UK, Germany, Spain, France, and Japan.
* For Pertussis, DelveInsight estimates that the total vaccinated population in the 7MM and China was 65,837,354 in 2020, where the US accounted for the 20,058,055 vaccination in 2020. It is important to mention that vaccination of pregnant women against pertussis has been strongly advised, however, in majority of countries the usage of vaccines is off-label. There is a high vaccination coverage for pregnant women in the UK.
Pertussis Overview
Pertussis, commonly known as whooping cough, is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. It spreads through respiratory droplets when an infected person coughs or sneezes. Pertussis typically starts with mild cold-like symptoms such as a runny nose, low-grade fever, and cough, but progresses to severe, uncontrollable coughing fits. The characteristic "whoop" sound may follow as the infected individual gasps for air. Pertussis is particularly dangerous for infants, who may experience apnea or pauses in breathing. Vaccination with the DTaP vaccine is the most effective way to prevent pertussis. However, immunity may wane over time, leading to outbreaks among both vaccinated and unvaccinated individuals. Prompt diagnosis and treatment with antibiotics can help reduce the severity and duration of symptoms, as well as limit the spread of the disease.
Learn more about Pertussis treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ [https://www.delveinsight.com/sample-request/pertussis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Pertussis Market
The Pertussis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Pertussis market trends by analyzing the impact of current Pertussis therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.
According to DelveInsight, the Pertussis market in 7MM is expected to witness a major change in the study period 2019-2032.
Pertussis Epidemiology
The Pertussis epidemiology section provides insights into the historical and current Pertussis patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Pertussis market report also provides the diagnosed patient pool, trends, and assumptions.
Explore more about Pertussis Epidemiology @ [https://www.delveinsight.com/report-store/pertussis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Pertussis Drugs Uptake
This section focuses on the uptake rate of the potential Pertussis drugs recently launched in the Pertussis market or expected to be launched in 2019-2032. The analysis covers the Pertussis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Pertussis Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Pertussis market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Pertussis Pipeline Development Activities
The Pertussis market report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Pertussis key players involved in developing targeted therapeutics.
Request for a sample report to understand more about the Pertussis pipeline development activities @ [https://www.delveinsight.com/sample-request/pertussis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Pertussis Therapeutics Assessment
Major key companies are working proactively in the Pertussis Therapeutics market to develop novel therapies which will drive the Pertussis treatment markets in the upcoming years are Sanofi Pasteur, Mitsubishi Tanabe Pharma, GlaxoSmithKline, ILiAD Biotechnologies, Serum Institute, Bilthoven, Vakzine Projekt Management GmbH (VPM), Cansino Bio, China National Biotec Group and Beijing Institute of Biological Products, and others.
Learn more about the emerging Pertussis therapies & key companies @ [https://www.delveinsight.com/sample-request/pertussis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Pertussis Report Key Insights
1. Pertussis Patient Population
2. Pertussis Market Size and Trends
3. Key Cross Competition in the Pertussis Market
4. Pertussis Market Dynamics (Key Drivers and Barriers)
5. Pertussis Market Opportunities
6. Pertussis Therapeutic Approaches
7. Pertussis Pipeline Analysis
8. Pertussis Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Pertussis Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Pertussis Competitive Intelligence Analysis
4. Pertussis Market Overview at a Glance
5. Pertussis Disease Background and Overview
6. Pertussis Patient Journey
7. Pertussis Epidemiology and Patient Population
8. Pertussis Treatment Algorithm, Current Treatment, and Medical Practices
9. Pertussis Unmet Needs
10. Key Endpoints of Pertussis Treatment
11. Pertussis Marketed Products
12. Pertussis Emerging Therapies
13. Pertussis Seven Major Market Analysis
14. Attribute Analysis
15. Pertussis Market Outlook (7 major markets)
16. Pertussis Access and Reimbursement Overview
17. KOL Views on the Pertussis Market
18. Pertussis Market Drivers
19. Pertussis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=pertussis-market-analysis-2032-epidemiology-fda-approvals-clinical-trials-therapies-companies-by-delveinsight-sanofi-pasteur-mitsubishi-tanabe-pharma-glaxosmithkline-iliad-biotechnologies]
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pertussis Market Analysis 2032: Epidemiology, FDA Approvals, Clinical Trials, Therapies, Companies by DelveInsight | Sanofi Pasteur, Mitsubishi Tanabe Pharma, GlaxoSmithKline, ILiAD Biotechnologies here
News-ID: 3468957 • Views: …
More Releases from ABNewswire
Happiness Brewed Emphasizes Values-Driven Black Friday Shopping as Donation Prog …
With Black Friday just two weeks away, Happiness Brewed-the coffee and tea shop that emerged from viral content reaching 64 million views-is reinforcing its position as a meaningful alternative to traditional holiday shopping. The brand's focus on spreading good vibes and supporting daily happiness rituals offers consumers a way to align their Black Friday purchases with their values.
The company's upcoming donation program, which will allow customers to contribute to good…
DIVEVOLK Announces Massive Black Friday 2025 Sale: Turning Smartphones into Prof …
New York, US - November 20, 2025 - DIVEVOLK, the pioneer in underwater touchscreen housing technology, today announced its highly anticipated Black Friday 2025 event [http://www.divevolkdiving.com/]. Running from November 20 through December 1 (CST), the event marks the company's most significant sale of the year, offering global divers the opportunity to upgrade their underwater imaging gear at unprecedented prices.
Image: https://www.abnewswire.com/upload/2025/11/14d0714f25b72ab31942df1791266bd6.jpg
For a limited time, DIVEVOLK is offering a flat 20% discount…
Bihar Foundation Bangkok Hosts "Food & Spirituality Evening 2025" - Showcasing B …
Under the dynamic leadership of Amit Kumar, Bihar Foundation Bangkok is emerging as a powerful cultural force in Southeast Asia, dedicated to promoting Bihar's spiritual legacy, wellness heritage, and tourism potential. The "Food & Spirituality Evening 2025" marks the beginning of a renewed global movement-uniting communities, governments, and tourism leaders to showcase Bihar as the Land of Enlightenment and a beacon of global spiritual tourism.
Bangkok, Thailand - 20 November, 2025…
AURA DEER Unveils Handcrafted Himalayan Jewelry Collection Celebrating Tibetan A …
AURA DEER [http://www.auradeer.com], an independent jewelry brand rooted in Tibetan cultural heritage, today announced the launch of its newest handcrafted spiritual jewelry collection ahead of the 2025 Black Friday shopping season. Designed for global audiences seeking meaningful and culturally inspired accessories, the collection introduces mala necklaces, gemstone talismans, protective amulets, and Tibetan-style pendants crafted with natural Himalayan materials and traditional symbolism. The full line is now available worldwide through AURA…
More Releases for Pertussis
Diphtheria, Pertussis, and Tetanus Vaccine Market
According to a new report published by Allied Market Research, titled, "Diphtheria, Pertussis, and Tetanus Vaccine Market by Product Type [DTaP (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel), Td (Decavac and Tenivac), and Tdap (Boostrix and Adacel)], Vaccine Type (Whole-Cell Vaccine and Acellular Vaccine), Age Group (Adult and Pediatric), and End User (Hospitals, Clinics, and Vaccination Centers) - Global Opportunity and Forecast, 2019-2026 ".
The Global market size of Diphtheria, Pertussis,…
Growth in Adoption of Pertussis Vaccination and Government Insurance are Project …
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free…
Global Pertussis Vaccine Consumption 2016 Market Research Report
The Global Pertussis Vaccine Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Pertussis Vaccine market.
First, the report provides a basic overview of the Pertussis Vaccine industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.
Secondly, the report states the global Pertussis Vaccine market size (volume and value),…
Pertussis Vaccine Market: Estimated to Flourish by 2016 - 2024
The Pertussis Vaccine Market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size.
Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S,…
Pertussis Vaccine Industry 2024 Market Research Report
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free…
Pertussis Vaccine Industry 2024 Market Research Report
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free…
